Exponent (EXPO) Getting Somewhat Positive Media Coverage, Analysis Shows

News headlines about Exponent (NASDAQ:EXPO) have been trending somewhat positive recently, Accern reports. The research firm rates the sentiment of press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Exponent earned a coverage optimism score of 0.06 on Accern’s scale. Accern also gave news stories about the business services provider an impact score of 47.2064644669678 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Here are some of the news stories that may have impacted Accern’s rankings:

Exponent opened at $50.35 on Friday, according to MarketBeat. The company has a market capitalization of $2.60 billion, a PE ratio of 43.52 and a beta of 0.59. Exponent has a 12-month low of $31.73 and a 12-month high of $52.63.

Exponent (NASDAQ:EXPO) last issued its earnings results on Thursday, July 19th. The business services provider reported $0.34 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.31 by $0.03. The business had revenue of $95.60 million for the quarter, compared to the consensus estimate of $89.42 million. Exponent had a net margin of 13.51% and a return on equity of 20.52%. The firm’s revenue for the quarter was up 8.9% on a year-over-year basis. During the same period in the previous year, the company earned $0.51 earnings per share. sell-side analysts predict that Exponent will post 1.27 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 21st. Shareholders of record on Friday, September 7th will be given a dividend of $0.13 per share. The ex-dividend date of this dividend is Thursday, September 6th. This represents a $0.52 dividend on an annualized basis and a yield of 1.03%. Exponent’s dividend payout ratio (DPR) is 48.60%.

Several brokerages have commented on EXPO. ValuEngine upgraded shares of Exponent from a “buy” rating to a “strong-buy” rating in a report on Tuesday, June 5th. BidaskClub upgraded shares of Exponent from a “buy” rating to a “strong-buy” rating in a report on Saturday, April 14th. Zacks Investment Research downgraded shares of Exponent from a “strong-buy” rating to a “hold” rating in a report on Wednesday, June 20th. SunTrust Banks lifted their price objective on shares of Exponent to $56.00 and gave the company a “buy” rating in a report on Friday, July 20th. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $24.00 price objective on shares of Exponent in a report on Friday, April 20th. Two investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $34.67.

In other Exponent news, insider Harri Kytomaa sold 2,639 shares of Exponent stock in a transaction on Friday, May 18th. The shares were sold at an average price of $94.04, for a total transaction of $248,171.56. Following the completion of the transaction, the insider now directly owns 8,045 shares of the company’s stock, valued at $756,551.80. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Debra Zumwalt sold 500 shares of Exponent stock in a transaction on Friday, May 25th. The stock was sold at an average price of $96.01, for a total transaction of $48,005.00. Following the transaction, the director now directly owns 6,940 shares of the company’s stock, valued at $666,309.40. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 5,375 shares of company stock valued at $406,702. Company insiders own 2.80% of the company’s stock.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.

See Also: How to Invest in Growth Stocks

Insider Buying and Selling by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply